Desperate patients get access to experimental Lab-Made vessels
NCT ID NCT07141641
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 33 times
Summary
This program offers individual patients with vascular disease or end-stage kidney disease on dialysis access to an experimental lab-grown blood vessel (ATEV) when all other treatments have failed and they cannot join a clinical study. The goal is to provide a potential option for those with no alternatives. The program is currently temporarily unavailable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
acellular tissue engineered vessel (ATEV)
What this could lead to
If successful, this could provide a new option for patients with vascular disease or on dialysis who have run out of standard treatments.
What could go wrong
This is an expanded access program, not a formal trial, so evidence is limited. The vessel may fail or cause complications, and long-term benefits are uncertain.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.